These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28058700)

  • 1. XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population.
    Santonocito C; Scapaticci M; Nedovic B; Annicchiarico EB; Guarino D; Leoncini E; Boccia S; Gasbarrini A; Capoluongo E
    Int J Biol Markers; 2017 May; 32(2):e190-e194. PubMed ID: 28058700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Li QW; Lu CR; Ye M; Xiao WH; Liang J
    Asian Pac J Cancer Prev; 2012; 13(1):191-4. PubMed ID: 22502666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    Xiong Y; Zhang Q; Ye J; Pan S; Ge L
    PLoS One; 2018; 13(11):e0206853. PubMed ID: 30408066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
    Li J; Li Z; Feng L; Guo W; Zhang S
    Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.
    Han X; Xing Q; Li Y; Sun J; Ji H; Huazheng P; Jun L
    Hepatogastroenterology; 2012 Oct; 59(119):2285-9. PubMed ID: 22456434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
    Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
    Wang YD; Zhai WL; Wang HY; Xia XQ
    Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
    Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
    Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
    Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
    Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population.
    Naguib M; Helwa MM; Soliman MM; Abdel-Samiee M; Eljaky AM; Hammam O; Zaghla H; Abdelsameea E
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1031-1037. PubMed ID: 32334466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population.
    Pan HZ; Liang J; Yu Z; Lun LM; Li H; Wang Q
    Asian Pac J Cancer Prev; 2011; 12(11):2947-50. PubMed ID: 22393969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of APEX1 p.Asp148Glu and XRCC1 p.Gln399Arg with the susceptibility of hepatocellular carcinoma.
    Saad AM; Abdel-Megied AES; Elbaz RA; Hassab El-Nabi SE; Elshazli RM
    J Med Virol; 2021 Nov; 93(11):6278-6291. PubMed ID: 34289138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations in DNA-repair genes (XRCC1, 3, and 7) and the susceptibility to hepatocellular carcinoma in a cohort of Egyptians.
    Aboul Enein AA; Khaled IAA; Khorshied MM; Abdel-Aziz AO; Zahran N; El Saeed AM; Shousha HI; Abdel Rahman HA
    J Med Virol; 2020 Dec; 92(12):3609-3616. PubMed ID: 32281666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk.
    Yuan T; Wei J; Luo J; Liu M; Deng S; Chen P
    Dig Dis Sci; 2012 Sep; 57(9):2451-7. PubMed ID: 22565339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.
    Xu W; Liu SA; Li L; Shen ZY; Wu YL
    Genet Mol Res; 2015 Jun; 14(2):7122-9. PubMed ID: 26125922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis between the c.1804C>A genetic polymorphism of XRCC1 gene and risk of hepatocellular carcinoma in Chinese population.
    Liu Y; Zhang A; Liu Y; Dong J
    Med Oncol; 2014 Mar; 31(3):854. PubMed ID: 24526467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.